BlackRock’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $62.2M | Buy |
10,890,440
+2,000,796
| +23% | +$9.08M | ﹤0.01% | 2533 |
|
|
2026
Q1 | $40M | Sell |
8,889,644
-6,414,206
| -42% | -$33.4M | ﹤0.01% | 2653 |
|
|
2025
Q4 | $94.1M | Buy |
15,303,850
+424,423
| +3% | +$3.08M | ﹤0.01% | 2137 |
|
|
2025
Q3 | $108M | Sell |
14,879,427
-192,832
| -1% | -$1.14M | ﹤0.01% | 2056 |
|
|
2025
Q2 | $80M | Sell |
15,072,259
-385,917
| -2% | -$2.28M | ﹤0.01% | 2193 |
|
|
2025
Q1 | $137M | Sell |
15,458,176
-449,417
| -3% | -$5.4M | ﹤0.01% | 1807 |
|
|
2024
Q4 | $218M | Buy |
15,907,593
+465,254
| +3% | +$8.58M | ﹤0.01% | 1619 |
|
|
2024
Q3 | $423M | Buy |
15,442,339
+291,533
| +2% | +$7.89M | 0.01% | 1192 |
|
|
2024
Q2 | $371M | Buy |
15,150,806
+271,487
| +2% | +$5.96M | 0.01% | 1205 |
|
|
2024
Q1 | $317M | Buy |
14,879,319
+220,970
| +2% | +$4.75M | 0.01% | 1327 |
|
|
2023
Q4 | $281M | Buy |
14,658,349
+1,031,424
| +8% | +$17.8M | 0.01% | 1411 |
|
|
2023
Q3 | $219M | Sell |
13,626,925
-477,679
| -3% | -$9.09M | 0.01% | 1473 |
|
|
2023
Q2 | $327M | Sell |
14,104,604
-23,104
| -0.2% | -$504K | 0.01% | 1232 |
|
|
2023
Q1 | $328M | Sell |
14,127,708
-228,391
| -2% | -$4.64M | 0.01% | 1205 |
|
|
2022
Q4 | $208M | Sell |
14,356,099
-227,096
| -2% | -$4.23M | 0.01% | 1504 |
|
|
2022
Q3 | $278M | Sell |
14,583,195
-175,205
| -1% | -$4.02M | 0.01% | 1228 |
|
|
2022
Q2 | $268M | Sell |
14,758,400
-39,429
| -0.3% | -$819K | 0.01% | 1306 |
|
|
2022
Q1 | $373M | Buy |
14,797,829
+113,042
| +0.8% | +$2.89M | 0.01% | 1190 |
|
|
2021
Q4 | $405M | Buy |
14,684,787
+1,123,482
| +8% | +$32.5M | 0.01% | 1199 |
|
|
2021
Q3 | $438M | Sell |
13,561,305
-42,365
| -0.3% | -$1.41M | 0.01% | 1090 |
|
|
2021
Q2 | $416M | Buy |
13,603,670
+373,791
| +3% | +$10.8M | 0.01% | 1177 |
|
|
2021
Q1 | $403M | Buy |
13,229,879
+727,959
| +6% | +$20.7M | 0.01% | 1200 |
|
|
2020
Q4 | $247M | Buy |
12,501,920
+89,486
| +0.7% | +$1.45M | 0.01% | 1453 |
|
|
2020
Q3 | $162M | Sell |
12,412,434
-219,989
| -2% | -$2.78M | 0.01% | 1559 |
|
|
2020
Q2 | $143M | Buy |
12,632,423
+173,737
| +1% | +$2.47M | 0.01% | 1594 |
|
|
2020
Q1 | $178M | Sell |
12,458,686
-293,433
| -2% | -$6.2M | 0.01% | 1251 |
|
|
2019
Q4 | $347M | Buy |
12,752,119
+276,739
| +2% | +$7.61M | 0.01% | 1086 |
|
|
2019
Q3 | $357M | Sell |
12,475,380
-59,966
| -0.5% | -$1.75M | 0.02% | 994 |
|
|
2019
Q2 | $348M | Buy |
12,535,346
+509,214
| +4% | +$14.4M | 0.01% | 1026 |
|
|
2019
Q1 | $399M | Sell |
12,026,132
-176,310
| -1% | -$5.37M | 0.02% | 893 |
|
|
2018
Q4 | $355M | Buy |
12,202,442
+735,832
| +6% | +$26.5M | 0.02% | 872 |
|
|
2018
Q3 | $527M | Buy |
11,466,610
+383,089
| +3% | +$17M | 0.02% | 730 |
|
|
2018
Q2 | $414M | Buy |
11,083,521
+691,243
| +7% | +$23.3M | 0.02% | 859 |
|
|
2018
Q1 | $307M | Buy |
10,392,278
+325,525
| +3% | +$11M | 0.01% | 1053 |
|
|
2017
Q4 | $346M | Buy |
10,066,753
+150,003
| +2% | +$5.06M | 0.02% | 956 |
|
|
2017
Q3 | $359M | Buy |
9,916,750
+467,223
| +5% | +$13.3M | 0.02% | 885 |
|
|
2017
Q2 | $244M | Sell |
9,449,527
-92,357
| -1% | -$1.96M | 0.01% | 1130 |
|
|
2017
Q1 | $183M | Buy |
9,541,884
+9,536,219
| +168,336% | +$169M | 0.01% | 1368 |
|
|
2016
Q4 | $94K | Sell |
5,665
-10,750
| -65% | -$194K | ﹤0.01% | 2577 |
|
|
2016
Q3 | $338K | Sell |
16,415
-1,232
| -7% | -$31.2K | ﹤0.01% | 1889 |
|
|
2016
Q2 | $539K | Buy |
17,647
+12,932
| +274% | +$449K | ﹤0.01% | 1641 |
|
|
2016
Q1 | $176K | Buy |
4,715
+2,604
| +123% | +$98.1K | ﹤0.01% | 1763 |
|
|
2015
Q4 | $91K | Buy |
2,111
+164
| +8% | +$6.93K | ﹤0.01% | 1804 |
|
|
2015
Q3 | $73K | Buy |
1,947
+28
| +1% | +$994 | ﹤0.01% | 1805 |
|
|
2015
Q2 | $66K | Sell |
1,919
-151
| -7% | -$5.13K | ﹤0.01% | 1888 |
|
|
2015
Q1 | $73K | Hold |
2,070
| – | – | ﹤0.01% | 1837 |
|
|
2014
Q4 | $71K | Sell |
2,070
-98
| -5% | -$3.48K | ﹤0.01% | 1826 |
|
|
2014
Q3 | $83K | Sell |
2,168
-4,377
| -67% | -$163K | ﹤0.01% | 1762 |
|
|
2014
Q2 | $255K | Buy |
6,545
+794
| +14% | +$29.5K | ﹤0.01% | 1445 |
|
|
2014
Q1 | $196K | Sell |
5,751
-5,202
| -47% | -$161K | ﹤0.01% | 1553 |
|
|
2013
Q4 | $230K | Buy |
10,953
+5,821
| +113% | +$147K | ﹤0.01% | 1566 |
|
|
2013
Q3 | $121K | Sell |
5,132
-22,063
| -81% | -$627K | ﹤0.01% | 1617 |
|
|
2013
Q2 | $730K | Buy |
+27,195
| New | +$788K | ﹤0.01% | 1129 |
|
Other funds holding MYGN
VPC
BlackRock's MYGN Position: Q2 2026 in Review
BlackRock increased its Myriad Genetics (MYGN) stake by 23% in Q2 2026, buying an estimated $9.08M and bringing the position to 10,890,440 shares worth $62.2M. The position accounts for ﹤0.01% of the portfolio, ranked #2533.
BlackRock first reported a position in MYGN in Q2 2013 and has held it in 53 quarters since. The position peaked at $527M in Q3 2018. 196 funds tracked by Wall St. Rank hold MYGN as of Q2 2026.
- BlackRock held 10,890,440 shares of Myriad Genetics worth $62.2M as of Q2 2026.
- BlackRock bought 2,000,796 Myriad Genetics shares in Q2 2026, an estimated $9.08M.
- Myriad Genetics made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #2533 holding.
- BlackRock first reported a position in Myriad Genetics in Q2 2013 and has held it in 53 quarters since.
- BlackRock's Myriad Genetics position peaked at $527M in Q3 2018.
- 196 funds tracked by Wall St. Rank held Myriad Genetics as of Q2 2026.
Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.